Showing results (31-40 of 62) with videos related to
Sort By:
Pageof 7
BMC Neurology|July 4, 2020
Induced neuroprotection by remote ischemic perconditioning as a new paradigm in ischemic stroke at the acute phase, a systematic reviewFrancisco Purroy, Cristina García, Gerard Mauri, et al.Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|March 17, 2023
Functional foods and nutraceuticals in the treatment of hypercholesterolemia: Statement of the Spanish Society of Arteriosclerosis 2023Pablo Pérez-Martínez, Emilio Ros, Juan Pedro-Botet, et al.Advances in Biochemical Engineering/Biotechnology|September 8, 2019
Gene TherapyAna Del Pozo-Rodríguez, Alicia Rodríguez-Gascón, Julen Rodríguez-Castejón, et al.Pharmaceutics|June 2, 2021
α-Galactosidase A Augmentation by Non-Viral Gene Therapy: Evaluation in Fabry Disease MiceJulen Rodríguez-Castejón, Ana Alarcia-Lacalle, Itziar Gómez-Aguado, et al.Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|July 29, 2018
Consensus document of the Spanish Society of Arteriosclerosis (SEA) for the prevention and treatment of cardiovascular disease in type 2 diabetes mellitusAntonio Ruiz-García, Ezequiel Arranz-Martínez, Ignacio Morón-Merchante, et al.Neurologia|December 28, 2020
The influence of organisational management on door-to-needle times for fibrinolytic treatmentM Vicente-Pascual, A Quilez, M P Gil, et al.Neurologia|July 16, 2022
The influence of organisational management on door-to-needle times for fibrinolytic treatmentM Vicente-Pascual, A Quilez, M P Gil, et al.Pharmaceutics|June 27, 2020
Topical Administration of SLN-Based Gene Therapy for the Treatment of Corneal Inflammation by De Novo IL-10 ProductionMónica Vicente-Pascual, Itziar Gómez-Aguado, Julen Rodríguez-Castejón, et al.Nanomedicine (London, England)|May 25, 2018
Gene delivery in the cornea: in vitro & ex vivo evaluation of solid lipid nanoparticle-based vectorsMónica Vicente-Pascual, Andrea Albano, María Á Solinís, et al.Drugs in Context|February 5, 2026
Optimizing care and quality indicators in the management of patients with acute ischaemic heart disease and atherothrombotic stroke: measuring to improveJosé R González-Juanatey, Rafael Vázquez-García, Raquel Campuzano, et al.Pageof 7